Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition

Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition

Integration of immune checkpoint inhibitors (ICIs) has improved the efficacy of treatment regimens for various cancers. The array of potential side effects keeps evolving and includes neurological complications. An increased risk of seizures and status epilepticus (SE) has been discussed and appears...

Full description

Bibliographic Details
Main Authors: Hans Urban, Laurent M. Willems, Michael W. Ronellenfitsch, Felix Rosenow, Joachim P. Steinbach, Adam Strzelczyk
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
brain metastases
status epilepticus
checkpoint inhibitors
anti-pd-1/pd-l1
anti ctla-4
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1851517

Internet

http://dx.doi.org/10.1080/2162402X.2020.1851517

Similar Items